Literature DB >> 1607128

Interleukin-1 beta and interleukin-6 mRNA are expressed in human glioblastoma and neuroblastoma cells respectively.

A Stephanou1, R A Knight, M Annicchiarico-Petruzzelli, A Finazzi-Agrò, S L Lightmann, G Melino.   

Abstract

We report the expression of different interleukins (IL) in four human glioblastoma and neuroblastoma cell lines. The glioblastoma cell line LI, expresses IL-1 beta and IL-6 mRNA, though not IL-2 and IL-4. The expression of the former gene is modulated by retinoic acid. Two cell clones [BE(2)-C and BE(2)-M17] as well as the neuroblastoma cell line SK-N-BE(2), from which both clones were derived, express IL-6 mRNA, but not IL-1 beta, IL-2 or IL-4. Both IL-1 beta and IL-6 cytokines are known to increase hypothalamic CRH mRNA, a gene reported to be expressed in all these cell lines. The production of both cytokines and neuropeptides indicates a complex dialogue between tumour cells and anti-tumour immunity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607128

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  4 in total

1.  A possible growth factor role of IL-6 in neuroectodermal tumours.

Authors:  E Candi; R A Knight; A Spinedi; P Guerrieri; G Melino
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo.

Authors:  Tammy Kielian; Nico van Rooijen; William F Hickey
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

3.  Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.

Authors:  L S Wang; K C Chow; C W Wu
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

4.  Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.

Authors:  Richard E Kast; Nicolas Skuli; Georg Karpel-Massler; Guido Frosina; Timothy Ryken; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2017-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.